Every year, more people die of adverse drug effects than in transportation accidents. Every day, thousands of pharmaceutical preparations are administered to patients who will not experience any relief at all, or much worse, who will suffer from toxicity and thus, eventually develop severe adverse effects.
Guidance to the physician is offered by pharmacogenetics, which is a key factor in the concept of personalized medicine. Pharmacogenetics uses genetic information to evaluate the patient's abilities to metabolise a drug (pharmacokinetics) or to bind a drug (drug targets). In the first case, testing usually consists of analysis of single nucleotide polymorphisms, or SNPs, of drug-metabolising enzymes, whereas in the second case, the target of a drug is analysed to check whether the drug efficiently binds to it.
Examples of our pharmacogenetic products: